P8A.SI stock moved sharply in after hours trading on 27 Feb 2026 when Cordlife Group Limited (P8A.SI) rose 14.62% to S$0.149 on the Singapore Exchange (SES). The jump came with a volume print of 13,400 shares versus a 30-day average of 17,498, producing a relative volume of 1.14. There was no company earnings release today, so the move looks driven by technical buying and a short-term oversold rebound. We flag the price action for traders watching high-volume movers late in the session.
Price and volume snapshot for P8A.SI stock
Cordlife (P8A.SI) closed after hours at S$0.149, up S$0.019 or 14.62% from a previous close of S$0.13. Intraday range was S$0.149-S$0.149. Reported volume was 13,400 versus an avgVolume of 17,498, giving a relative volume of 1.14. The stock trades on the SES in Singapore and has a market capitalisation of S$38,189,854. Technical averages are 50-day: S$0.1412 and 200-day: S$0.1963.
What likely triggered the move and trading context
There was no earnings or corporate announcement today; the earningsAnnouncement field is null. The price uptick looks technical: the stock had an RSI of 29.70 and CCI of -198.80, both signalling oversold conditions that can attract short-covering and rebound buying. The day’s bounce also follows a year low of S$0.121 and a one-year decline near -3.87%, so momentum traders often target such setups in after hours. Given limited public news, monitor order flow and block trades into the next session for confirmation.
P8A.SI stock: valuation and financial metrics
Cordlife’s trailing metrics show mixed fundamentals. EPS is -0.05 and reported PE is -2.98, reflecting negative earnings. The price-to-book ratio is 0.34 and book value per share is S$0.4373. Liquidity sits with sharesOutstanding: 256,307,744. Cordlife reports a current ratio of 3.13 and cash per share: S$0.2032, which supports short-term balance-sheet resilience. Investors should note negative net income per share of -0.0330 and free cash flow per share -0.0289, indicating continued operating cash pressure.
Meyka AI rates P8A.SI with a score out of 100 and forecast
Meyka AI rates P8A.SI with a score of 62.15 out of 100 and assigns a Grade: B (HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month level of S$0.4617 versus the current S$0.149, implying an upside of 210.09%. Forecasts are model-based projections and not guarantees. Use this alongside fundamentals; the grade reflects mixed ratios, modest market cap, and recovery potential in our scenario analysis.
Sector context and risks for P8A.SI stock
Cordlife operates in Healthcare, Medical – Diagnostics & Research, a sector with average PE near 21.66 and average current ratios higher than many peers. Cordlife’s valuation (PB 0.34) is below Healthcare peers, suggesting value or structural weakness. Key risks include negative profitability, lengthy receivables cycles (days sales outstanding 255.59), and thin trading liquidity. Sector performance has been mixed year-to-date; compare wider Healthcare trends before allocating capital.
Trading outlook, targets and strategy for this high-volume mover
For active traders, short-term resistance sits near the 50-day average S$0.1412 (already tested) and the 200-day S$0.1963. Recommended intraday/short-term targets: S$0.18 (near-term), S$0.25 (6-month), and model-driven 12-month target S$0.4617. Set a risk guard: a stop-loss below S$0.13 aligns with recent support. Watch liquidity: average volume is light, so use size discipline. For investors, wait for sustained revenue or margin improvement before adding weight.
Final Thoughts
Key takeaways: P8A.SI stock jumped 14.62% in after hours to S$0.149 on 27 Feb 2026 with a modest volume lift to 13,400 shares, signalling a technical rebound from oversold territory. The balance sheet shows healthy current ratio 3.13 and cash per share S$0.2032, but earnings remain negative with EPS -0.05 and PE -2.98. Meyka AI rates the stock 62.15/100 (B, HOLD) and flags a model forecast of S$0.4617 in 12 months, implying ~210.09% upside from today’s price; forecasts are projections, not guarantees. For high-volume mover strategies, treat this as a watchlist entry: confirm follow-through volume in the SES regular session and prefer staged exposure or trading-sized positions until fundamentals show steady recovery. For more real-time data and the Cordlife company page see Cordlife P8A.SI on Meyka.
FAQs
Why did P8A.SI stock move after hours today?
The after-hours move to S$0.149 (+14.62%) appears technical, driven by oversold indicators (RSI 29.70) and short-covering, not by an earnings release. Volume was modestly higher than average at 13,400 shares, so watch next-session order flow.
What valuation metrics matter for P8A.SI stock?
Key metrics: EPS -0.05, PE -2.98, PB 0.34, book value per share S$0.4373, and current ratio 3.13. These show a weak earnings profile but reasonable balance-sheet liquidity.
What is Meyka AI’s forecast and how should I use it for P8A.SI stock?
Meyka AI’s forecast model projects S$0.4617 in 12 months versus the current S$0.149, implying ~210.09% upside. Use this as a scenario input, not a guarantee, and combine it with fresh earnings and volume confirmation.
How should traders approach P8A.SI in the SES after this spike?
Traders should confirm follow-through volume in the regular session, use tight position sizing because liquidity is thin, set stop-loss near S$0.13, and target short-term resistance at S$0.18 and S$0.25 with strict risk controls.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)